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Nogo-A and myelin-associated glycoprotein differently regulate
oligodendrocyte maturation and myelin formation
Abstract
Nogo-A is one of the most potent oligodendrocyte-derived inhibitors for axonal regrowth in the injured
adult CNS. However, the physiological function of Nogo-A in development and in healthy
oligodendrocytes is still unknown. In the present study, we investigated the role of Nogo-A for myelin
formation in the developing optic nerve. By quantitative real-time PCR, we found that the expression of
Nogo-A increased faster in differentiating oligodendrocytes than that of the major myelin proteins MBP
(myelin basic protein), PLP (proteolipid protein)/DM20, and CNP (2',3'-cyclic nucleotide
3'-phosphodiesterase). The analysis of optic nerves and cerebella of mice deficient for Nogo-A
(Nogo-A(-/-)) revealed a marked delay of oligodendrocyte differentiation, myelin sheath formation, and
axonal caliber growth within the first postnatal month. The combined deletion of Nogo-A and MAG
caused a more severe transient hypomyelination. In contrast to MAG(-/-) mice, Nogo-A(-/-) mutants did
not present abnormalities in the structure of myelin sheaths and Ranvier nodes. The common binding
protein for Nogo-A and MAG, NgR1, was exclusively upregulated in MAG(-/-) animals, whereas the
level of Lingo-1, a coreceptor, remained unchanged. Together, our results demonstrate that Nogo-A and
MAG are differently involved in oligodendrocyte maturation in vivo, and suggest that Nogo-A may
influence also remyelination in pathological conditions such as multiple sclerosis.
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Nogo-A is one of the most potent oligodendrocyte-derived inhibitors for axonal regrowth in the injured adult CNS. However, the physi-
ological function of Nogo-A in development and in healthy oligodendrocytes is still unknown. In the present study, we investigated the
role ofNogo-A formyelin formation in the developing optic nerve. By quantitative real-timePCR,we found that the expression ofNogo-A
increased faster in differentiating oligodendrocytes than that of themajormyelin proteinsMBP (myelin basic protein), PLP (proteolipid
protein)/DM20, and CNP (2,3-cyclic nucleotide 3-phosphodiesterase). The analysis of optic nerves and cerebella of mice deficient for
Nogo-A (Nogo-A/) revealed a marked delay of oligodendrocyte differentiation, myelin sheath formation, and axonal caliber growth
within the first postnatal month. The combined deletion of Nogo-A and MAG caused a more severe transient hypomyelination. In
contrast toMAG/mice, Nogo-A/mutants did not present abnormalities in the structure ofmyelin sheaths andRanvier nodes. The
common binding protein for Nogo-A andMAG, NgR1, was exclusively upregulated in MAG/ animals, whereas the level of Lingo-1, a
coreceptor, remained unchanged. Together, our results demonstrate that Nogo-A and MAG are differently involved in oligodendrocyte
maturation in vivo, and suggest that Nogo-Amay influence also remyelination in pathological conditions such as multiple sclerosis.
Key words:Nogo-A; oligodendrocyte; myelination; OPC; optic nerve; cerebellum
Introduction
In the CNS, the myelinating cells are the oligodendrocytes that
derive from oligodendrocyte precursor cells (OPCs) generated in
the ventricular zone (Kessaris et al., 2006). As oligodendrocytes
differentiate and produce myelin sheets, they start expressing
high levels ofmyelin basic protein (MBP) andproteolipid protein
(PLP) constituting most of the myelin protein content. The cen-
tral role of those proteins inmyelination is illustrated by defect in
structure stability of themyelin sheath inMBP or PLP knock-out
(KO) mice (Popko et al., 1987; Griffiths et al., 1998). In contrast,
little is known about the functional role of other myelin proteins
in oligodendrocyte differentiation.
Nogo-A is a high molecular weight transmembrane protein
that was initially identified as a potent myelin-associated inhibi-
tor for axonal growth expressedmostly by oligodendrocytes (Ca-
roni and Schwab, 1988; Chen et al., 2000). In the injured spinal
cord, treatments with neutralizing antibodies against Nogo-A or
Nogo-A gene deletion stimulate long-range axonal growth and
improve locomotor functions (Schwab, 2004; Dimou et al.,
2006). Nogo-A binds to amultisubunit receptor complex includ-
ing the Nogo66 receptor NgR1 (Fournier et al., 2001), the adap-
tor molecule Lingo-1 (Mi et al., 2004), and the effector compo-
nents p75/Troy (Shao et al., 2005). The stimulation of this
complex at the surface of neurons leads to the intracellular acti-
vation of the small GTPase RhoA that mediates actin depolymer-
ization and thereby the collapse or retraction of neurites (Ya-
mashita et al., 2005). The same molecular cascade can be elicited
by MAG and oligodendrocyte myelin glycoprotein (OMgp),
which are structurally different fromNogo-A but bind also to the
NgR–p75 receptor complex (Wang et al., 2002a).
Molecules related to Nogo-A signaling, such as MAG and
Lingo-1, have been shown to be involved in oligodendrocyte de-
velopment. Lingo-1was recently shown to be a negative regulator
of oligodendrocyte differentiation in vitro and in vivo (Mi et al.,
2005).MAG, a cell surface Ig superfamily protein, is present at the
periaxonal membrane of oligodendrocytes where it mediates ax-
on–oligodendrocyte adhesion (Owens et al., 1990; Owens and
Bunge, 1991). Surprisingly, constitutive MAG/ mice showed
only a slight delay in myelination and subtle abnormalities in the
myelin structure (Li et al., 1994; Montag et al., 1994). This could
be attributable to compensating mechanisms involving, for ex-
ample, Nogo-A, which, likeMAG, can bind the NgR complex. In
the first 2 postnatal weeks, Nogo-A protein and mRNA levels
were detected in many neurons including retinal ganglion cells,
in addition to oligodendrocytes (Huber et al., 2002; Wang et al.,
2002b). This period corresponds to oligodendrocyte differentia-
tion and to the beginning of myelination. It is thus possible that
the developmentally regulated expression of Nogo-A participates
to axoglial contact and/or oligodendrocyte maturation.
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In this study, we investigated the differ-
entiation of oligodendrocytes and myeli-
nation in knock-out animals deficient for
Nogo-A or MAG or in double knock-outs
(DOKOs). The ablation of Nogo-A caused
a severe but transient impairment of oligo-
dendrocyte differentiation and produc-
tion of myelin. In contrast to MAG, how-
ever, the lack of Nogo-A did not alter the
structure ofmyelin or the node of Ranvier.
Materials andMethods
Animals: knock-out animal generation. Animal
procedures were performed in agreement with
the guidelines of the Veterinary Office of the
Canton of Zurich. Nogo-A knock-out mice
were generated by homologous recombination
of exons 2 and 3 in Nogo-A gene as described
previously (Simonen et al., 2003). The MAG-
null mice were obtained by homologous re-
combination of mag gene from exons 5–8 in-
cluding the region encoding the signal sequence
(Montag et al., 1994). For single and double
knock-outmice, the strain background reached
99% C57BL/6. Double knock-out mutants
were obtained by crossing Nogo-A/ and
MAG/mice. The transgenic strain was rou-
tinely genotyped by PCRs using the following
primer sequences for Nogo-A/ phenotype:
5-AGT GAG TACCCAGCT GCA C-3, 5-
CCT ACC CGG TAG AAT ATC GAT AAG
C-3, 5-TGC TTT GAA TTA TTC CAAGTA
GTC C-3; and for MAG/ phenotype: 5-
TTG GCG GCG AAT GGG CTG AC-3, 5-
GCA GGG AAT GGA GAC ACA CG-3, 5-
CAC CCT GCC GCT GTT TTG GAT AAT-3.
Quantitative real-time PCR. At different ages
ranging from postnatal day 0 (P0) to adult-
hood, cerebella, optic nerves, or retinas were
rapidly dissected in RNAlater solution (Am-
bion) after cervical dislocation. The tissueswere
placed in Eppendorf tubes, flash frozen in liq-
uid nitrogen, and stored at 80°C until RNA
extraction. The RNeasy RNA isolation kit
(QIAGEN) was used for retinal and cerebellar
samples, whereas optic nerve RNA was pre-
pared with the RNeasy Micro kit (QIAGEN).
Residual genomic DNA was digested by DNase
treatment. For reverse transcription, the same
amounts of total RNA were transformed by
oligo-dT and M-MLV reverse transcriptase
(Promega). For all tissues, cDNAs correspond-
ing to 5 ng of total RNA were amplified with
specific primers designed to span intronic se-
quences or cover exon–intron boundaries.
Primers specific for CNP (forward, 5-AG-
GAGAAGCTTGAGCTGGTC; reverse, 3-
CGATCTCTTCACCACCTCCT), GAPDH
(forward, 5-CAGCAATGCATCCTGCACC;
reverse, 3-TGGACTGTGGTCATGAGCCC),
LINGO1 (forward, 5-AAGTGGCCAGTTCA-
TCAGGT; reverse, 3-TGTAGCAGAGC-
CTGACAGCA), MAG (forward, 5-GAT-
GATATTCCTCGCCACC; reverse, 3-ACTG-
ACCTCCACTTCCGTT),MBP (forward, 5-CACACACGAGAACTAC-
CCA; reverse, 3-GGTGTTCGAGGTGTCACAA), NgR1/RTN4R (for-
ward, 5-CTCGACCCCGAAGATGAAG; reverse, 3-TGTAGCACA-
CACAAGCACCAG),NogoA/RTN4 (forward, 5-CAGTGGATGAGAC-
CCTTTTTG; reverse, 3-GCTGCTCCTTCAAATCCATAA), PLP/
DM20 (forward, 5-TCAGTCTATTGCCTTCCCTAGC; reverse, 3-
AGCATTCCATGGGAGAACAC). Gene expression was analyzed by
real-time reverse transcription (RT)-PCR with a polymerase ready mix
(LightCycler 480; SYBR Green I Master; Roche) and a thermocycler
Figure1. Nogo-A is inversely regulated in oligodendrocytes and retinal neurons duringdevelopment.A, ThemRNAexpression
ofmyelin-associatedproteinswas followedbyqRT-PCR in theoptic nerve frombirthuntil adulthood (Ad). TheelevationofNogo-A
mRNApreceded thatof othermarkers for oligodendrocytesbya fewdays.B, The transcripts ofNogo-Adramatically increasedafter
P3 in the oligodendrocytes of the optic nerve but underwent a parallel downregulation in the ganglion cell layer of the
oligodendrocyte-free retina. Error bars indicate SEM. C–F, Single-scan confocal pictures of P8 optic nerve sections showed that
Nogo-A was present in typical rows of interfascicular oligodendrocytes. Only a few of these immature Nogo-A-positive cells also
showed a staining for L-MAG (D) or for CNP (G) as shown by superimposing the two labelings (E, H, stars). Most of the Nogo-A
expressing cells were not yet expressing L-MAG or CNP staining (arrowheads). I, By immunohistochemistry, the signal of Nogo-A
was very intense in the retinal ganglion cell layer and in the optic nerve (ON) axons at P1. In the adult retina, the weak
Nogo-A labeling was restricted to the innermost layer of the retina. J, Double immunostainings for Nogo-A (red) and PLP-GFP
(green) in P15 optic nerve are shown by single-scan confocal microscopy. The superimposition of the two stainings shows the
presence of Nogo-A in axon fascicles (small arrows) and the coexpression of Nogo-A and PLP in differentiated oligodendrocytes
(yellow, large arrowhead) and their processes. K, Unlike Nogo-A, L-MAG (red) and PLP-GFP (green) are exclusively found in
oligodendrocytes (yellow) in the optic nerve. ON, Optic nerve. Scale bars: C–H, 100m; I, 200m; J, K, 50m.
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(LightCycler; Roche Diagnostics). The analysis of the melting curve of
each amplified PCR product and the visualization of the PCR amplicons
on 1.5% agarose gels allowed to control the specificity of the amplifica-
tion. For relative quantification of gene expression, mRNA levels were
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
using the comparative threshold cycle (CT)method. For calibration, a
control sample was used to calculate the relative values, as indicated in
the figure legend. Each reaction was done in triplicate.
Immunohistochemistry.At different ages (P0 to adult),micewere killed
by injecting an overdose of anesthetic intraperitoneally. After intracar-
diac perfusion with PBS (0.1 M) and 4% paraformaldehyde (PFA), the
eyes and the brain were rapidly dissected and postfixed in 4% PFA for
48 h at 4°C. The tissueswere cryoprotected in 30%sucrose overnight, and
then frozen in OCT (optimal cutting temperature) compound (Tissue-
Tek; Sakura Finetek) with a liquid nitrogen-cooled bath of
2-methylbutane. Longitudinal brain sections (20 m), optic nerves sec-
tions (10 m), and retinal sections (12 m) were cut with a cryostat and
collected on Superfrost Plus slides (Menzel-Glaser). For immunohisto-
chemistry procedure, tissue slices were blockedwith 5%BSA, 3%normal
serum, 0.3% Triton X-100 in PBS for 1 h at room temperature to avoid
unspecific crossreactivity. Then, primary antibodies were applied in 5%
BSA, 3% normal serum, 0.3% Triton X-100 in PBS overnight at 4°C.
After PBS washes, sections were incubated with the appropriate second-
ary antibody for 1 h at room temperature and mounted with MOWIOL
anti-fading medium [10%Mowiol 4–88 (w/v) (Calbiochem) in 100 mM
Tris, pH 8.5, 25% glycerol (w/v), and 0.1% DABCO (1,4-
diazabicyclo[2.2.2]octane)]. Primary antibodies were as follows: rabbit
anti-Nogo-A [Laura; Rb173A (Oertle et al., 2003)] serum (1:200), rabbit
anti-MBP (1:1000; Millipore Bioscience Research Reagents; AB980),
mouse anti-green fluorescent protein (GFP) (clone 3E6; Invitrogen),
rabbit anti L-MAG (1:500; gift from Dr. N. Schaeren-Wiemers, Univer-
sity Hospital Basel, Pharmacenter, Basel, Switzerland), rabbit anti-olig2
(1:4000–1:10,000; provided byDr. C. Stiles, HarvardUniversity, Boston,
MA), mouse anti-adenomatous polyposis coli (APC) (1:1000; clone
CC-1; Calbiochem), guinea pig anti-NG2 (1:500; given by Dr. W. Stall-
cup, Burnham Institute for Medical Research, Cancer Research Center,
La Jolla, CA). Immunofluorescent labelings were analyzed with Zeiss
Axioskop 2 Plus microscope (Carl Zeiss) and images were taken with a
CCD video camera.
Paranodin/sodium channel labeling. Alternatively, for paranodin/
Caspr and sodium channel double stainings in the optic nerve, fresh
frozen cryosections were cut immediately after animal decapitation
and placed at 80°C. Slides were thawed and dried at room temper-
ature, fixed in absolute methanol for 20 min at 20°C, and washed
three times with PBS. As described previously, the preincubation was
done for 30 min to 1 h at room temperature. Mouse anti-pan sodium
channel (1:50–1:100; clone K58/35; Sigma-Aldrich) and rabbit anti-
paranodin (1:500; gift from Dr. J.-A. Girault, Universite´ Pierre et
Marie Curie, Paris, France) were applied on slices and left overnight at
4°C. For sodium channel (NaCh) staining, a horse anti-mouse biotin-
coupled antibody (1:100; Vector) was added for 2 h at room temper-
ature and a third incubation was performed with streptavidin linked
to Alexa 488 (1:400; Invitrogen). A goat anti-rabbit antibody (1:1000;
Invitrogen) was used to detect paranodin. Image stacks were acquired
by confocal microscopy in the chiasmal region (caudal) of the optic
nerve. Two to four picture stacks were sampled in a slice volume of
119.05  119.05  5 m per animal and for the different groups.
Calculations of paranodin and NaCh clusters were made on merged
pictures in NIH software.
Western blot. Mice were killed by cervical dislocation and retinas,
cerebellum, or optic nerve were quickly dissected out and flash frozen
in liquid nitrogen. Tissues were stored at 80°C until extraction in
lysis buffer (10 mM Tris-HCl, 1% Nonidet 40, 150 mM NaCl, 0.1%
SDS, 1% deoxycholate, pH 7.4) containing protease inhibitors (Com-
plete Mini; Roche Diagnostics). The samples were homogenized on
ice for 30 min. After centrifugation for 15 min at 10,000 g and 4°C,
the supernatant was retrieved in new Eppendorf tubes and kept at
80°C or 20°C. Proteins (50–100 g) were separated by electro-
phoresis on a 4–12% polyacrylamide gel and transferred to polyvi-
nylidene difluoride Immobilon P membranes. Blots were preincu-
bated in a blocking solution of 5% BSA in 0.2% TBST (0.1 M Tris base,
0.2% Tween 20, pH 7.4) for 1 h at room temperature, incubated with
primary antibodies overnight at 4°C and after washing, with a
horseradish peroxidase-conjugated anti-rabbit antibody (1:10,000–
Figure 2. Effects of Nogo-A and MAG deletion on oligodendrocyte precursor cell number andmigration in the optic nerve. A, Optic nerve longitudinal sections (10m thick) were labeled with
an antibody recognizing Olig2 in oligodendrocyte precursor cells and inmature oligodendrocytes between E17.5 and P28. Olig2-stained OPC cells migrated from the optic chiasm (OC) at E17.5 and
colonized the optic nerve until the optic nerve head (ONH) at later stages. Inset, Comparative examination of Olig2 staining in the rostral region of the WT and DOKO optic nerve showed a lower
density of cells in DOKO thanWT at P8 but not at P15.B, Quantitative analysis of the density of Olig2-labeled cells in the optic nerve ofWT, Nogo-A/, MAG/, and DOKOmice between P0 and
P28. The average density (mean SEM) of cells was normalized to the surface of the optic nerve. For each time point, two to seven animals were examined. Scale bars: A, 400m; inset, 100m.
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1:25,000; Pierce Biotechnology). Primary an-
tibodies were rabbit anti-MBP (1:250–1:500;
Millipore Bioscience Research Reagents),
rabbit anti-NgR1 (1:250–1:500; R&D Sys-
tems), rabbit anti-Lingo-1 (1:500; Abcam),
and anti-GAPDH (1:10,000; Abcam). Protein
bands were detected by adding SuperSignal
West Pico Chemiluminescent Substrate
(Pierce) by exposing the blot in a Stella detec-
tor (Raytest). Densitometry analysis was per-
formed with NIH software and by normaliz-
ing the band intensities to GAPDH values.
Electron microscopy.Mice were perfused int-
racardially at P15 and at P28 with a solution
containing 2% of PFA and 2% of glutaralde-
hyde diluted in Sorensen buffer (0.067 M). Im-
mediately after perfusion, optic nerves were
dissected and postfixed for 3 d in the same fix-
ative mixture at 4°C. The midoptic nerves were
cut in two pieces with scissors and then incu-
bated for 3 h in 2% osmium tetroxide (PB; 0.1
M) at room temperature under gentle rotary ag-
itation. The tissues were dehydrated in graded
baths of ethanol, immersed in propylene oxide,
and embedded in epoxy resin. Polymerization
was made at 60°C for 5 d. Semithin cross-
sections of 0.7min thicknesswere cut for light
microscopy inspection, whereas ultrathin sec-
tions of 50 nmwere cut for electronmicroscopy
analysis. Pictures were taken randomly in cen-
tral and peripheral optic nerves at 4400 or
8800.
Results
Nogo-A is developmentally regulated in
neurons and oligodendrocytes
Wemonitored Nogo-AmRNA expression
changes in glial and neuronal cells by
quantitative RT-PCR (qRT-PCR) in the
developing mouse optic nerve and in the
retina, respectively (Fig. 1). The visual sys-
tem was ideal to discriminate neuronal
from glial Nogo-A because the optic nerve
is deprived of neuronal cell bodies and the
retina does not contain oligodendrocytes
in rodents. Nogo-A mRNA expression in-
creased 5- to 10-fold after P3 in the optic nerve, preceding that of
the main structural myelin proteins MBP, PLP, and 2,3-cyclic
nucleotide 3-phosphodiesterase (CNP) by 2–3 d (Fig. 1A). The
maximal mRNA expression for all these oligodendrocyte pro-
teins was reached at P15. OnlyNogo-AmRNAwasmaintained at
a high level in the adult, whereas MBP, PLP/DM20, CNP, and
MAG dropped by60,72,84, and85%, respectively. The
elevation of MBP mRNA by RT-PCR was correlated with the
detection of MBP protein by immunohistochemistry, in the ros-
tral optic nerve (data not shown). MBP immunostaining then
spreads in a rostral-to-caudal direction as previously reported
(Foran andPeterson, 1992). Interestingly, the increase ofNogo-A
mRNA in the optic nerve (400%) between birth and adulthood
was paralleled by a 50% decrease in the retina (Fig. 1B). By
immunohistochemistry at P8, Nogo-Awas detected inmany pre-
sumptive oligodendrocytes of P8 optic nerves (Fig. 1C,E,F,H,
arrowheads), whereas only a few of those cells coexpressed the
myelin proteins L-MAG (Fig. 1D,E, stars) or CNP (Fig. 1G,H,
stars). The detection of Nogo-A protein by immunohistochem-
istry corroborates the qRT-PCR results suggesting that Nogo-A
expression precedes other oligodendrocytic markers during de-
velopment. Moreover, Nogo-A was located in the retinal gan-
glion cell layer and in optic axons at P1, whereas in the adult the
Nogo-A signal was restricted to the innermost layer of the retina
and became undetectable in the oligodendrocyte-free part of the
optic nerve (Fig. 1 I). Control stainings on Nogo-A/ sections
or by omitting the incubationwith the primary antibody onwild-
type (WT) slices failed to provide a signal (data not shown).
Nevertheless, as oligodendrocyte differentiation was proceeding
at P10, Nogo-A coexisted in unmyelinated axons and in the pro-
cesses of differentiating, PLP-GFP-positive oligodendrocytes in
the optic nerve (Fig. 1 J), suggesting that the neuron-to-glia
switch of Nogo-A expression occurs progressively. As expected,
MAG was only observed in oligodendrocyte cell bodies and pro-
cesses (Fig. 1K). Together, these results show that glial Nogo-A
upregulation occurs rapidly and early at the time of oligodendro-
cyte differentiation, whereas in neurons Nogo-A expression is
progressively downregulated.
Figure3. Oligodendrocyte differentiation andmyelin protein synthesis are impaired inNogo-A- andMAG-deficientmice.A,B,
Oligodendrocyte differentiation was visualized by MBP immunostaining in longitudinal sections of optic nerves at P8 (A) and of
cerebella at P15 (B). The intensity of MBPwas substantially weaker inmutant optic nerves and cerebella than inWT tissues. MBP
staining was the lowest for the DOKO group in which the signal was restricted to the optic nerve head (arrowhead) and was
particularly low in the granule cell layer of the cerebellum (GCL) and in the white matter. C, D, The relative mRNA levels of MBP,
PLP, and CNP were analyzed at P10 in the optic nerves and in the cerebella by qRT-PCR. At least three animals per group were
analyzed in triplicate. For eachmyelin protein, themRNA levelwas normalized usingGAPDHas internal standard and represented
in percentage ofWT values. Themost noticeable reductions ofmyelin proteinmRNAs appeared in Nogo-A/ tissues. Error bars
indicate SEM. E, MBP protein isoforms were strongly reduced in all three KO cerebella at P15 as seen by Western blots (50g
proteins/lane). At P35, no difference was noted. Scale bars: A, B, 200m.
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Nogo-A and/or MAG suppression does not prevent
oligodendrocyte precursor cell migration in the optic nerve
Because Nogo-A was early detected in the retinal ganglion cell
axons and oligodendrocytes, we speculated that Nogo-A may
influence the migration of OPCs. In the CNS, the optic nerve is a
place of choice to observeOPC invasion occurring from the optic
chiasm to the optic nerve head (Small et al., 1987; Colello et al.,
1995; Ueda et al., 1999; Sugimoto et al., 2001). OPCs were visu-
alized by using an antibody directed against Olig2, a bHLH (basic
helix-loop-helix) transcription factor specifically expressed in
OPC nuclei (Lu et al., 2000; Zhou et al., 2000). On longitudinal
sections, a small number of Olig2-positive [Olig2-()] cells
emerged from the optic chiasm at embryonic day 17.5 (E17.5)
and then invaded the optic nerve in a chiasma-to-retina gradient
(Fig. 2A). As expected, OPCs did not penetrate into the retina
and stopped migrating in the optic nerve head by P4. Until P6,
Olig2 was found in glial precursors immunostained for NG2
(data not shown). It persisted in differen-
tiated oligodendrocytes that were recog-
nized by PLP-GFP staining at P10 or APC
antigen at P15 (data not shown). At the
different ages, the density of olig2-labeled
cells per square millimeter of optic nerve
was evaluated in WT, Nogo-A/,
MAG/, and DOKO animals (Fig. 2B).
In WT, the density of Olig2-() cells in-
creased fourfold between P0 and P6 and
peaked at P10. Then, the density of Olig2-
() cells steadily declined at P15 and P28.
In single knock-out mice, increase and de-
cline of Olig2-() cells clearly followed
that of WT. In contrast, the density of
Olig2-() cells in DOKO plateaued after
P6 but reached WT levels at P15 and P28
(Figs. 1A, 2B, insets). Quantitatively, the
reduction of labeled cells in DOKO repre-
sented 26% at P8 and 29% at P10 of
the WT group values.
Deletion of Nogo-A orMAG induces a
delay in oligodendrocyte differentiation
in the CNS
To observe oligodendrocyte differentia-
tion, we followed the expression of thema-
jor oligodendrocyte and myelin markers
MBP, PLP, and CNP in optic nerves and
cerebella by immunohistochemistry, qRT-
PCR, andWestern blot analysis (Fig. 3). In
the optic nerve ofNogo-A/orMAG/
P8 mouse pups, MBP immunostaining
was severely decreased compared withWT
animals and an evenmore dramatic reduc-
tion was found in the DOKO group, in
which MBP staining was restricted to the
most rostral part of the optic nerve (Fig.
3A). Consistent with this, Nogo-A/ and
MAG/ cerebella presented less MBP-
positive axons in the granule cell layer and
reduced staining of thewhitematter at P15
compared with WT mice. Again, an even
more striking reduction was observed in
the DOKO pups that showed only a few
MBP-positive fibers in the granule cell
layer (GCL) (Fig. 3B). Surprisingly, the qRT-PCR analysis re-
vealed that theNogo-A/mice had themostmarked reductions
of MBP, PLP/DM20, and CNP mRNA levels, whereas MAG/
animals presented virtually no difference relative to the WT
group in the cerebellum and in the optic nerve at P10. In the
DOKO animals, myelin protein mRNA levels were similar to
those of MAG/ mice in the optic nerve, but equal to Nogo-
A/ mice in the cerebellum (Fig. 3C,D). Western blot analysis
showed a strong reduction of the four MBP isoforms in the cer-
ebella of Nogo-A/, MAG/, and DOKO mice at P15 (Fig.
3E). These results suggest that the absence of Nogo-A compro-
mised myelin protein synthesis, whereas absence of MAG may
primarily affect deposition and myelin formation or stability. At
P35, the amount of MBP reached comparable levels in all four
groups, suggesting that oligodendrocyte differentiation is de-
layed rather than prevented by the absence of Nogo-A or MAG.
Figure 4. Nogo-A andMAG influence myelination and growth of optic axons. A–H, At P15 and P28, the myelination of axons
was examined by electron microscopy on midway along KO optic nerves. A–D, At P15, less myelinated axons than in WT nerves
weredetected inNogo-A/andMAG/optic nerves andmuch less inDOKO.E–H, Thedensity ofmyelinatedaxons increased
in all groups at P28. I, Quantitationof thepercentageofmyelinatedaxons at P15andP28 (***p	0.001, *p	0.05, ANOVA;N

3–4 animals/group). At P15, the number of measured axons per groupwas 1178 axons inWT, 1873 axons in Nogo-A/, 1737
axons inMAG/, and1543axons inDOKO; at P28, 1549axons inWT, 1869axons inNogo-A/, 1806axons inMAG/, and
1570 axons in DOKO were evaluated. J, In the same samples, the spectrum of axon calibers was determined. At P15, the axon
diameter profileswere shifted to smaller axon sizes in theKOnerves comparedwithWTmice.K, Axon caliberswere close to theWT
values at P28. Error bars indicate SEM. Scale bars: A–H, 3m.
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Developing optic nerves of Nogo-A/,
MAG/, and DOKOmice are
hypomyelinated
We analyzed myelin formation in optic
nerves by electron microscopy at P15 and
P28 (Fig. 4). At P15, 71 4% ofWT axons
were myelinated in contrast to 28 2% in
Nogo-A/, 33  1% in MAG/, and
21  2% in DOKO mice (Fig. 4A–D,I)
(mean  SEM; N 
 3; *p 	 0.05, ***p 	
0.001, ANOVA). At P28, the density of
myelinated axons increased in all groups
(Fig. 4E–H) reaching 71  1% in WT,
63  4% in Nogo-A/, 63  2% in
MAG/, and 63 5% inDOKO animals
(Fig. 4 I) (mean  SEM; N 
 3–4; p 
0.05, ANOVA). The large but transitory
deficit of myelinated axons revealed here
by the EM analysis is consistent with the
oligodendrocyte differentiation defects
described above.
Myelination is known to control the
axonal diameter growth in normal animals
(Colello et al., 1994; Cellerino et al., 1997).
To determine whether the axon was also
affected in our hypomyelinated mice, the
axonal diameter distribution was assessed
for each group at P15 and P28. At P15, the
axonal caliber profiles of the three KO
groups were markedly shifted to smaller
dimensions (Fig. 4 J). Whereas the mean
diameter of WT axons was0.80 m, the
mean axon caliber was 0.61 m in
Nogo-A/ andDOKO, and0.67min
MAG/ mice, with sizes up to 2.8 m.
All KO groups had an axon caliber signif-
icantly different from WT mice at P15
(*p	 0.05, ANOVA). At P28, the axon size
distribution was not statistically different
between KO and WT mice ( p  0.05,
ANOVA): themean axon diameter was0.7m inNogo-A/,
0.75 m in DOKO, and 0.8 m in MAG/ and WT optic
nerves (Fig. 4K). Interestingly, the deletion of Nogo-A caused a
stronger reduction of the axonal growth at P15 than the deletion
of MAG.
Mature optic nerves of Nogo-A//MAG/ double KOmice
showmyelin abnormalities
The number of myelinated axons in KO mice was not distin-
guishable from WT animals at P28, but this does not mean that
the myelin structure is normally formed. We thus analyzed the
myelin abnormalities in the KO andWT optic nerves at P28 (Fig.
5). DOKO optic nerves showed different kinds of myelin abnor-
malities such as myelin outfolds (Fig. 5B, arrows), multiple my-
elin rings (Fig. 5B, arrowhead), uncompacted myelin sheaths,
and lack or excess of cytoplasm in the periaxonal space. The
quantitation of those abnormalities revealed that DOKOhad sig-
nificantly more aberrances thanWT optic nerves (Fig. 5D) (*p	
0.05, ANOVA). Interestingly, themyelin structure ofNogo-A/
axons appeared to be not different from WT axons, whereas
MAG/ axons exhibited a similar number of abnormalities as
DOKO axons (Fig. 5D). This suggests that myelin abnormalities
encountered in DOKO are mostly a consequence of the absence
of MAG.
Formation of nodes of Ranvier
Ranvier nodes are crucial for the function of myelinated axons.
They are characterized by a very high density of voltage-gated
sodium channels, surrounded on each side by a band containing
paranodin/Caspr in the paranodal segments (Menegoz et al.,
1997; Dupree et al., 1999). MAG/mice are known to have an
abnormal distribution of paranodin and sodium channels at the
nodes of Ranvier (Marcus et al., 2002).When we stained P15WT
optic nerve sections for paranodin and sodium channels, the typ-
ical narrow bands of sodium channels were flanked on each side
by paranodin-positive clusters (Fig. 6A). The paranodin/sodium
channel triplets had a normal appearance and density in Nogo-
A/ optic nerves (Fig. 6B). In contrast, MAG/ and DOKO
mice showed many heminodes and single paranodin or sodium
channel clusters (Fig. 6C,D). The counting of nodes, heminodes,
and single paranodes revealed a similar number of nodal patterns
inWTandNogo-A/nerves and confirmed that paranodin and
sodium channel localization is disrupted in absence ofMAG (Fig.
6E) (**p	 0.01, ANOVA). TheDOKOnerves were intermediate
between WT/Nogo-A/ and MAG/ nerves. These results
Figure 5. The myelin structure presents abnormalities in MAG/ and DOKO but not in Nogo-A/ optic nerves at P28.
Electron micrographs representing myelinated axons in WT and DOKO optic nerves at P28. A–C, Compared with WT axons (A),
many DOKO axons (B, C) displayed abnormalities such as myelin sheath outfolds (B, arrows), multiple myelin sheaths (B, arrow-
head), and myelin compaction defects around the axons (C, arrow). D, The quantification of abnormally myelinated axons
consisted of counting blindly the aberrantmyelin outfolds, multiplemyelin ensheathment, the uncompactedmyelin sheath, and
lack or excess of cytoplasm in the periaxonal space. For that, 692 axons inWT, 532 axons in Nogo-A/, 407 axons inMAG/,
and 379 axons in DOKO were randomly analyzed in three to four different optic nerves. The percentage of abnormalities was
significantly increased in DOKO optic nerves (37.9 5.6%) compared with WT (17.5 3.7%) (*p	 0.05, ANOVA). However,
Nogo-A/ (12.1 5.6%) and WT, or MAG/ (32.2 6.1%) and DOKO were not statistically different. This suggests that
Nogo-A deletion does not affect the myelin structure and that the elevated abnormalities found in DOKO optic nerves are mostly
attributable to the absence of MAG. Error bars indicate SEM. Scale bars: A, B, 2m; C, 0.6m.
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suggest that, in contrast to MAG, Nogo-A does not play a central
function in the establishment of the nodes of Ranvier.
Developmental time course and KO-induced changes of
Nogo-A/MAG receptor components
Recent studies demonstrated that Lingo-1, a membrane protein
that can associate with the Nogo-A and MAG binding protein
NgR, in neurons (Lee et al., 2007) or glial cells (Mi et al., 2005) can
exert an inhibitory effect on oligodendrocyte maturation. The
relative importance of neuronal versus glial Lingo-1 in this pro-
cess is unclear. We first looked at the expression of Lingo-1 by
qRT-PCR in the optic nerve, in the retina, and in the cerebellum
during oligodendrocyte development. Lingo-1 was dramatically
downregulated in the WT optic nerve after P6, a time coinciding
with the beginning of oligodendrocyte differentiation (Fig. 7A).
The level of Lingo-1 mRNA in the retina was lower than in the
optic nerve and it decreased only after P15. In the cerebellum,
Lingo-1 expression increased until P10, started decreasing at P15,
and was low in the adult (Fig. 7B). Thus, the downregulation of
Lingo-1 in glia coincided in time with the onset of oligodendro-
cyte maturation (optic nerve) more than in neurons (retina).
We then wanted to determine whether the elimination of
Nogo-A and/or MAG resulted in a compensatory change of
Lingo-1. The levels of Lingo-1 mRNA by qRT-PCR and Lingo-1
protein by Western blots did not show differences between
Nogo-A/, MAG/, or DOKO and WT cerebellar samples
(Fig. 7C,D). Defects in oligodendrocyte maturation in Nogo-A
and MAG-deficient animals is therefore unlikely attributable to
Lingo-1.
NgR1 is a receptor component associated with Lingo-1 to
whichMAGand theNogo66 sequence can bind. InWT cerebella,
the level of NgR1 mRNA increased from P6, peaked at P15, and
remained high in adults (Fig. 8A). At P10, NgR1 mRNA levels
were not different betweenmutant andWT animals (Fig. 8B). At
P15 and P35, however, Western blot analysis showed a robust
upregulation of the NgR1 protein level in MAG/ and DOKO
cerebella, whereas in Nogo-A/ mice, NgR1 appeared un-
changed compared with WT animals (Fig. 8C). Densitometric
quantification revealed that NgR1 bands inMAG/ andDOKO
samples were1.7–2 times as strong as inWT extracts (Fig. 8D).
The specific increase of NgR1 protein in MAG/ and DOKO
tissues suggests that the regulation of NgR1 expression in neu-
rons is MAG-dependent and Nogo-A-independent.
Nogo-A as well as MAG can bind to NgR1 (Fournier et al.,
2001; Liu et al., 2002). To check whether the absence of
Nogo-A and MAG induces a compensatory upregulation of
the other molecule, we looked at MAG and Nogo-A mRNA
levels in Nogo-A/, MAG/, and DOKO mice. In Nogo-
A/ mice, MAG expression was decreased by 23% com-
pared with the WT level (**p 	 0.01, ANOVA). This statisti-
cally significant reduction of MAG is very likely a consequence
of the delay of oligodendrocyte differentiation described
above. In addition, the separation of MAG transcripts by aga-
rose gel electrophoresis revealed that the predominant splice
version of MAG switched from L-MAG in P6–P15 optic nerve
to S-MAG in adult optic nerves; this switch occurred in a
similar manner for WT and Nogo-A/ mice (data not pre-
sented). In contrast to the reduction of MAG in Nogo-A/
animals, inMAG/mice the expression of Nogo-A was iden-
tical with that of the WT control. These measurements show
that MAG or Nogo-A deletion does not induce a compensat-
ing upregulation of the other ligand for NgR1/Lingo-1 and
further points to separate functions played by Nogo-A and
MAG on oligodendrocyte development.
Discussion
Our study shows that Nogo-A is involved in oligodendrocyte
development in vivo. Nogo-A was expressed in the optic nerve
before themajormyelin proteinsMBP, PLP, andCNP.MAG/,
Nogo-A/, and DOKO all showed a delay of oligodendrocyte
differentiation and severe hypomyelination at P15. The hypomy-
elination in the optic nerve recovered by P28. Nevertheless,
Figure 6. Distribution of paranodin and sodium channels at the nodes of Ranvier in Nogo-
A/, MAG/, and DOKO optic nerves. A–D, Optic nerve sections were double-stained for
paranodin/Caspr (red) and sodium channels (NaCh; green) at P15. By confocal microscopy,
image stacks were captured and merged. A, The WT optic nerve shows NaCh clusters typically
flanked by two paranodin/Caspr-labeled paranodes. B, In Nogo-A/ nerves, the pattern of
NaCh/paranodin organization was indistinguishable to that of the WT. C, D, In contrast,
MAG/ and, to a lesser extent, DOKO mice often presented separate paranodin and NaCh
clusters. E, The distribution of paranodin-positive elements in nodes, heminodes, and single
paranodes was calculated. In MAG/ optic nerves, only11% of the paranodes were fully
assembled (**p	 0.01, ANOVA) compared with42% in WT,47% in Nogo-A/, and
25% in DOKO (*p	 0.05, ANOVA) optic nerves. Paranodin/Caspr clusters were more fre-
quently found as single paranodes in MAG/ (65%) and DOKO (52%) optic nerves in
comparison with WT (38%) and Nogo-A/ (32%) animals. Error bars indicate SEM.
Scale bar: 50 mm; 16.7m (insets).
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MAG/ andDOKO, but not Nogo-A/
animals, displayed abnormalities of the
myelin structure and the nodes of Ranvier.
The Nogo receptor subunit NgR1 was up-
regulated in MAG/ and DOKO but not
in Nogo-A/ tissues.
Nogo-A expression is involved in
oligodendrocyte differentiation
The expression of Nogo-A in the optic
nerve increased before that of constitutive
myelin proteins such as PLP andMBP and
may therefore be an important regulatory
factor for oligodendrocyte differentiation
and myelination. In contrast to MAG,
Nogo-A is expressed not only by oligoden-
drocytes but also by retinal ganglion cell
axons, before OPCs colonize the optic
nerve. Thus, axonal and/or glial Nogo-A
could influence oligodendrocyte matura-
tion via axon-to-oligodendrocyte or oligo-
dendrocyte-to-oligodendrocyte interac-
tions. The latter mechanism is supported
by a recent study showing that neutralizing
antibodies againstNogo-A blocked the dif-
ferentiation of oligodendrocytes cultured
in the absence of neurons (Zhao et al.,
2007).WhetherNogo-A participates to the
spatial distribution and architecture of oli-
godendrocytes in white matter through
glia-to-glia interactions remains to be in-
vestigated. Themigration of OPCs was un-
changed in MAG/ or Nogo-A/ optic
nerves, although themigration of neuronal
precursors in the cortex was previously
shown to be affected when Nogo-A/B/C
proteins were ablated (Mingorance-Le
Meur et al., 2007).
Myelin formation is differently impaired by Nogo-A and
MAG deletion
Themyelin formation wasmarkedly delayed in bothNogo-A/
and MAG/mice, and even more in DOKOmice at P15. Axon
diameterswere concomitantly reduced, probably as a result of the
myelination defect (Colello et al., 1994). Interestingly, we ob-
served obvious structural differences between MAG/ and
Nogo-A/ mice, especially with regard to defects of Ranvier
node formation that occurred in the MAG/ but not in the
Nogo-A/mice. The combined deletion of Nogo-A and MAG
in DOKO did not enhance the abnormalities of myelin structure
or Ranvier nodes compared with MAG/ mice, and MAG or
Nogo-A deletion did not induce the mutual upregulation of the
other protein. All these results suggest that these twomyelin pro-
teins fulfill distinct functions in the myelin formation. Nogo-A
seems to be mostly involved in oligodendrocyte differentiation,
whereas MAG appears to be implicated in the myelin structure
formation and in the axoglial contact.
The hypomyelination observed at P15 in KO tissues almost
completely disappeared at P28. Previous studies have shown the
powerful ability of the CNS to compensate for the deletion of
important structural myelin proteins or when OPCs are partially
ablated during the first postnatal week: in absence of the principal
myelin protein PLP, oligodendrocytes still assemble compact
myelin sheaths in the CNS (Klugmann et al., 1997). If oligoden-
drocytes are eliminated within the first postnatal week of life,
newly generated oligodendrocytes can fully compensate for the
myelination deficit by day 45 (Collin et al., 2004). Given this
remarkable compensatory capacity of the CNS for myelination
defects, it is not surprising to find a normal proportion of my-
elinated axons in our Nogo-A/, MAG/, and DOKO optic
nerves at 1 month. It will be interesting to study whichmolecular
pathways are involved in this compensatory effects in the Nogo-
A/ and MAG/ animals.
MAG and Nogo-A activate distinct molecular pathways
The differences in the myelin defects in MAG/ and Nogo-
A/ animals point to distinct underlying molecular mecha-
nisms. For example, the mRNA levels for PLP, MBP, and CNP
were markedly reduced in the Nogo-A/ cerebella at P10 but
not in the corresponding MAG/ tissues. Surprisingly, at the
same age, the level of myelin protein transcripts was similar in
DOKO as in MAG/ mice. This suggests that MAG deletion
may activate compensatory mechanisms that bring myelin pro-
tein transcripts to normal levels despite the absence of Nogo-A.
Such a compensatory change specific for MAG removal was in
fact observed by the upregulation of NgR1 in MAG/ and
DOKO but not in Nogo-A/. This is particularly astonishing
because NgR1 is a common binding partner for MAG and
Nogo-A. It was previously reported that MAG ablation caused
Figure 7. Developmental time course of Lingo-1 in WT and KO mice. A, The time course of Lingo-1 mRNA was assessed in
oligodendrocyte-free retinal samples and in neuron cell body-free, oligodendrocyte-containing optic nerves by qRT-PCR. The
amount of Lingo-1 transcripts dropped after P6 in the optic nerve and after P15 in the retina.B, In the cerebellum, Lingo-1mRNA
peaked at P10 and then decreased to low adult levels. In A, 100%, retinal level at P0; in B, P10 value. C, Lingo-1mRNA levels did
not differ between KO andWT cerebella at P10. All qRT-PCRmeasurements were normalized using GAPDH as internal reference.
Error bars indicate SEM.D, ByWestern blot analysis, the levels of Lingo-1 protein (100g/lane)were undistinguishable between
the groups. The experiments were repeated three times with three animals per group and experiment.
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N-CAM overexpression, which could partially compensate for
the missing adhesive functions of MAG (Montag et al., 1994). A
possibility is that NgR1 is not increased in Nogo-A/mice be-
cause of theNogo-Bupregulation (Simonen et al., 2003).Nogo-B
also contains the NgR1 binding region Nogo66 (Fournier et al.,
2001; Simonen et al., 2003). This would indicate, however, that
the myelin phenotype encountered in young Nogo-A/ mice
could be caused by anNgR1-independent signaling pathway. Be-
side the Nogo66 fragment that stimulates NgR1, a unique do-
main in the middle portion of Nogo-A has been shown to
strongly inhibit cell spreading and neurite growth by interacting
with a yet-uncharacterized receptor (Oertle et al., 2003). The
changes of NgR1 in theMAG/mice suggest that NgR1may be
necessary for MAG function in myelination. An intracellular sig-
nal triggered by MAG is the increased phosphorylation of the
tyrosine kinase Fyn, which can then drive MBP expression
(Umemori et al., 1999). However,MAG can interact with various
molecules on the axonal membrane such as NgR1 or NgR2, gan-
gliosides, and OMgp (Chen et al., 2006; Laure´n et al., 2007).
Downstream intracellular mediators could involve the small GT-
Pases of the Rho family such as RhoA, Cdc42, and Rac (Thurn-
herr et al., 2006; Zhao et al., 2007). Interestingly, the NgR1 inter-
acting membrane protein Lingo-1 has been shown to inhibit
oligodendrocyte differentiation (Mi et al., 2005). How and
whether the NgR1/Lingo-1 complex serves as a key receptor for
the Nogo-A and MAG-mediated effects on oligodendrocytes as
observed in the present study remains to be analyzed in detail.
Clinical relevance of Nogo-A in
demyelinating diseases
Our findings showing that Nogo-A plays
an important role for oligodendrocyte dif-
ferentiation is particularly relevant in the
context of myelin repair [e.g., in experi-
mental autoimmune encephalomyelitis
(EAE), in multiple sclerosis, or after CNS
trauma]. The absence of Nogo-A, or anti-
bodies directed against Nogo-A were
shown to block or dampen the appearance
of the EAE symptoms, possibly by decreas-
ing local inflammatory processes (Karnezis
et al., 2004). Our results showing the posi-
tive effects of Nogo-A for oligodendrocyte
differentiation should be taken into ac-
count when designing treatment sched-
ules; Nogo-A neutralization may have a
beneficial effect early during the inflam-
matory process or for regenerating axons
after CNS trauma, but it could be negative
for the process of myelin repair at a later
stage.
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